Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q4 FY26 results · Jan–Mar 2026
Metropolis Healthcare reported revenue from operations of ₹424.68 crore (up 23.0% from Q4 FY25) and net profit of ₹50.96 crore (up 74.3% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 424.68 | 345.29 | +23.0% | 405.91 | +4.6% |
| Other income | 8.16 | 6.97 | +17.1% | 9.02 | −9.5% |
| Total income | 432.84 | 352.26 | +22.9% | 414.93 | +4.3% |
| Profit before tax | 69.76 | 36.04 | +93.5% | 57.16 | +22.1% |
| Net profit for the period | 50.96 | 29.23 | +74.3% | 42.09 | +21.1% |
| Attributable to shareholders of the company | 50.90 | 29.14 | +74.7% | 41.39 | +23.0% |
| EPS, basic (₹) | 2.46 | 5.69 | not comparable | 7.99 | not comparable |
| Net margin (%) | 12.0 | 8.5 | 10.4 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 352.03 | 311.95 | +12.8% | 334.78 | +5.2% |
| Other income | 8.82 | 7.60 | +16.1% | 2.22 | +297.9% |
| Total income | 360.85 | 319.55 | +12.9% | 337.00 | +7.1% |
| Profit before tax | 59.61 | 28.64 | +108.2% | 42.32 | +40.9% |
| Net profit for the period | 43.24 | 23.85 | +81.3% | 32.03 | +35.0% |
| EPS, basic (₹) | 2.09 | 4.65 | not comparable | 6.18 | not comparable |
| Net margin (%) | 12.3 | 7.6 | 9.6 |
Consolidated
- Filed with BSE
- 13 May 2026, 21:17 IST
- Board meeting
- 13 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 May 2026, 21:17 IST
- Board meeting
- 13 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE